Avista Healthcare Partners has announced the acquisition of Trillium Health Care Products from New Water Capital.

Trillium, based in Brockville, Ontario, Canada, is a manufacturer of prescription and over-the­‐counter life science-based products for the North American market.

Avista

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Avista Acquires Trillium Health Care Products From New Water

Argosy Healthcare Partners (AHP) has announced the recapitalization of Connect Life Sciences (CLS).

CLS, founded in 2020 and based in Orlando, Florida, provides recruitment services to pharmaceutical, biotechnology and medical device companies.

AHP, based in Wayne, Pa., is

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Argosy Invests in Connect Life Sciences

Altaris has announced it will acquire Sharecare (NASDAQ: SHCR) for $1.43 in cash per share, or about $518 million.

Sharecare, founded in 2010 and based in Atlanta, is a digital health company that provides technology and services across the

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Altaris to Acquire Sharecare for $518 Million

Vista Equity Partners will acquire Model N (NYSE: MODN) for approximately $1.25 billion, according to a news release.

Model N, founded in 1999 and based in San Mateo, Calif., is a provider of revenue optimization and compliance software

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Vista to Acquire Model N for $1.25 Billion

New Mountain Capital will sell ILC Dover to Ingersoll Rand for about $2.3 billion, according to industry reports.

ILC, founded in 1947 and based in Frederica, Del., designs and produces solutions for the biopharmaceutical, pharmaceutical and medical device

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: New Mountain to Sell ILC Dover for $2.3 Billion

Arsenal Capital Partners will acquire Fortrea’s enabling services segment and patient access businesses, according to a news release.

Fortea (Nasdaq: FTRE), a global clinical research organization based in Research Triangle Park, N.C., is divesting its Endpoint Clinical and Fortrea

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Arsenal Acquires Multiple Companies From Fortrea